[The production of immunomodulating polypeptides by the thymus during its acute (accidental) involution in children].
Zaĭrat'iants. O V OV; Khavinson. Kh V KhV; Kuz'menko. L G LG
Key Findings
- Acute thymus involution in children leads to a progressive drop in thymalin production
- The drop occurs in both infectious and non‑infectious diseases
- Thymalin levels return to normal during the recovery phase
Practical Outcomes
- The study confirms that thymalin levels fall during acute illness, but it offers no dosage, safety, or supplementation guidance for adults. For biohackers, the main takeaway is that thymalin is linked to immune status, yet there’s insufficient evidence to create a practical protocol for self‑use.
Summary
In children who are sick, the thymus makes less of the immune‑boosting peptide thymalin, and the amount goes back up when they recover.
Abstract
The content of the thymalin polypeptides in the thymus is studied in the course of the 1st to 4th stages of the acute thymus involution in children dying from noninfectious and infectious disease. The results obtained were compared to the level of the circulating thymic factor and the number of T- and 'O' lymphocytes in the circulating blood of children with identical diseases and control group of the same age. It is concluded that the acute involution of the thymus in children with non-infectious and acute infectious diseases results in the progressive decrease of the production by the thymus of the immunomodulating polypeptides (thymic hormones) which is restored in the period of recovery.
Study Information
pubmed
1990